Ascentage Pharma Group International (AAPG) Work In Process (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Work In Process for 3 consecutive years, with $3.6 million as the latest value for Q4 2025.
- For Q4 2025, Work In Process rose 839.14% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, up 839.14%, while the annual FY2025 figure was $3.6 million, 870.05% up from the prior year.
- Work In Process hit $3.6 million in Q4 2025 for Ascentage Pharma Group International, up from $380894.2 in the prior quarter.
- Across five years, Work In Process topped out at $3.6 million in Q4 2025 and bottomed at $380894.2 in Q4 2024.
- Average Work In Process over 3 years is $1.6 million, with a median of $706797.9 recorded in 2023.
- Year-over-year, Work In Process tumbled 46.11% in 2024 and then soared 839.14% in 2025.
- Ascentage Pharma Group International's Work In Process stood at $706797.9 in 2023, then plummeted by 46.11% to $380894.2 in 2024, then skyrocketed by 839.14% to $3.6 million in 2025.
- According to Business Quant data, Work In Process over the past three periods came in at $3.6 million, $380894.2, and $706797.9 for Q4 2025, Q4 2024, and Q4 2023 respectively.